As soon as the news of the novel coronavirus, which originated in Wuhan, China, broke in early January, scientists at the historic University of Oxford began to work on a vaccine. Just three months later, the university announced promising results in monkeys and its vaccine, called ChAdOx1 nCoV019,
As soon as the news of the novel coronavirus, which originated in Wuhan, China, broke in early January, scientists at the historic University of Oxford began to work on a vaccine.
“The reason I chose to volunteer for this vaccine trial is because when I saw it on Twitter, my first instinct was to want to do something useful,” Courtie, a former TV presenter, told ABC News. “And I know that scientists find it really hard to find human volunteers for things. So I thought, well, here's a way that I can kind of redress the balance a bit and maybe help.
His daughter was rejected from the trial during the extensive screening stage. In addition to filling out forms of his medical history and taking a COVID-19 test to insure he has not yet had the disease, the university required a psychological background check. Last week, Courtie was given an injection, though crucially he does not know whether he is part of the control group or was given the vaccine.
“One of the things that I've not really shared with anyone yet, because it's only recently happened, is the palpable excitement that there is at the Jenner Institute,” he said. “I was saying, isn't it brilliant, you know, that, you know, these scientists, there's a race on here and we're in first place. You know, we're going to do it. And she was saying it's so exciting. Everybody here feels like we're doing it.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
What it's like inside the Oxford trial leading the race for coronavirus vaccineWith over 100 potential vaccines in development around the world, according to the WHO, the team at the U.K.'s University of Oxford appears to be at the front of the pack.
Read more »
What it's like inside the Oxford trial leading the race for coronavirus vaccineWith over 100 potential vaccines in development around the world, according to the WHO, the team at the U.K.'s University of Oxford appears to be at the front of the pack.
Read more »
Coronavirus vaccine in human trials relies on body's genetic materialIt's still unclear if the drug will work, and would be months away from potentially being available to the public, but the drug is now a contender to be the first vaccine of its kind ever approved to prevent an infectious disease.
Read more »
Moderna shares surge after FDA approves coronavirus vaccine for phase 2 trialModerna has received FDA approval for the company's Covid-19 vaccine to continue into the second phase. CNBC's Becky Quick reports.
Read more »
The FDA Has Approved a Coronavirus Vaccine for Phase Two TrialThe FDA has given Moderna the green light to enter into phase two of trials with its vaccine against the novel coronavirus that causes COVID-19
Read more »
Pfizer, BioNTech set to begin U.S. coronavirus vaccine trialPfizer Inc and BioNTech SE said on Tuesday they have begun delivering doses of their experimental coronavirus vaccines for initial human testing in the United States.
Read more »